Literature DB >> 22692092

Prevalence of transmitted antiretroviral drug resistance differs between acutely and chronically HIV-infected patients.

Elizabeth L Yanik1, Sonia Napravnik, Christopher B Hurt, Ann Dennis, E Byrd Quinlivan, Joe Sebastian, Joann D Kuruc, Joseph J Eron.   

Abstract

The associations of acute HIV infection (AHI) and other predictors with transmitted drug resistance (TDR) prevalence were assessed in a cohort of HIV-infected, antiretroviral-naïve patients. AHI was defined as being seronegative with detectable HIV RNA. Binomial regression was used to estimate prevalence ratios and 95% confidence intervals for associations with TDR. Among 43 AHI patients, TDR prevalence was 20.9%, whereas prevalence was 8.6% among 677 chronically infected patients. AHI was associated with 1.9 times the prevalence of TDR (95% confidence intervals: 1.0 to 3.6) in multivariable analysis. AHI patients may represent a vanguard group that portends increasing TDR in the future.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22692092      PMCID： PMC3458150          DOI： 10.1097/QAI.0b013e3182618f05

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


  22 in total

1.  Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission.

Authors:  Davey M Smith; Joseph K Wong; Hai Shao; George K Hightower; Stephanie H T Mai; Joseph M Moreno; Caroline C Ignacio; Simon D W Frost; Douglas D Richman; Susan J Little
Journal:  J Infect Dis       Date:  2007-06-19       Impact factor: 5.226

2.  Factors associated with fewer visits for HIV primary care at a tertiary care center in the Southeastern U.S.

Authors:  Sonia Napravnik; Joseph J Eron; Rosemary G McKaig; Amy D Heine; Prema Menezes; Evelyn Quinlivan
Journal:  AIDS Care       Date:  2006

3.  Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006.

Authors:  William H Wheeler; Rebecca A Ziebell; Helena Zabina; Danuta Pieniazek; Joseph Prejean; Ulana R Bodnar; Kristen C Mahle; Walid Heneine; Jeffrey A Johnson; H Irene Hall
Journal:  AIDS       Date:  2010-05-15       Impact factor: 4.177

4.  Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.

Authors:  Linda Wittkop; Huldrych F Günthard; Frank de Wolf; David Dunn; Alessandro Cozzi-Lepri; Andrea de Luca; Claudia Kücherer; Niels Obel; Viktor von Wyl; Bernard Masquelier; Christoph Stephan; Carlo Torti; Andrea Antinori; Federico García; Ali Judd; Kholoud Porter; Rodolphe Thiébaut; Hannah Castro; Ard I van Sighem; Céline Colin; Jesper Kjaer; Jens D Lundgren; Roger Paredes; Anton Pozniak; Bonaventura Clotet; Andrew Phillips; Deenan Pillay; Geneviève Chêne
Journal:  Lancet Infect Dis       Date:  2011-02-25       Impact factor: 25.071

5.  Repeat HIV testing: high-risk behaviour or risk reduction strategy?

Authors:  S Leaity; L Sherr; H Wells; A Evans; R Miller; M Johnson; J Elford
Journal:  AIDS       Date:  2000-03-31       Impact factor: 4.177

6.  This place is killing me: a comparison of counties where the incidence rates of AIDS increased the most and the least.

Authors:  Thomas A Peterman; Catherine A Lindsey; Richard M Selik
Journal:  J Infect Dis       Date:  2005-02-01       Impact factor: 5.226

7.  Late presentation for human immunodeficiency virus care in the United States and Canada.

Authors:  Keri N Althoff; Stephen J Gange; Marina B Klein; John T Brooks; Robert S Hogg; Ronald J Bosch; Michael A Horberg; Michael S Saag; Mari M Kitahata; Amy C Justice; Kelly A Gebo; Joseph J Eron; Sean B Rourke; M John Gill; Benigno Rodriguez; Timothy R Sterling; Liviana M Calzavara; Steven G Deeks; Jeffrey N Martin; Anita R Rachlis; Sonia Napravnik; Lisa P Jacobson; Gregory D Kirk; Ann C Collier; Constance A Benson; Michael J Silverberg; Margot Kushel; James J Goedert; Rosemary G McKaig; Stephen E Van Rompaey; Jinbing Zhang; Richard D Moore
Journal:  Clin Infect Dis       Date:  2010-06-01       Impact factor: 9.079

8.  Transmission of drug-resistant HIV-1 is stabilizing in Europe.

Authors:  Jurgen Vercauteren; Annemarie M J Wensing; David A M C van de Vijver; Jan Albert; Claudia Balotta; Osamah Hamouda; Claudia Kücherer; Daniel Struck; Jean-Claude Schmit; Birgitta Asjö; Marie Bruckova; Ricardo J Camacho; Bonaventura Clotet; Suzie Coughlan; Zehava Grossman; Andrzej Horban; Klaus Korn; Leondios Kostrikis; Claus Nielsen; Dimitrios Paraskevis; Mario Poljak; Elisabeth Puchhammer-Stöckl; Chiara Riva; Lidia Ruiz; Mika Salminen; Rob Schuurman; Anders Sonnerborg; Danica Stanekova; Maja Stanojevic; Anne-Mieke Vandamme; Charles A B Boucher
Journal:  J Infect Dis       Date:  2009-11-15       Impact factor: 5.226

9.  Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.

Authors:  Diane E Bennett; Ricardo J Camacho; Dan Otelea; Daniel R Kuritzkes; Hervé Fleury; Mark Kiuchi; Walid Heneine; Rami Kantor; Michael R Jordan; Jonathan M Schapiro; Anne-Mieke Vandamme; Paul Sandstrom; Charles A B Boucher; David van de Vijver; Soo-Yon Rhee; Tommy F Liu; Deenan Pillay; Robert W Shafer
Journal:  PLoS One       Date:  2009-03-06       Impact factor: 3.240

10.  Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection.

Authors:  Susan J Little; Simon D W Frost; Joseph K Wong; Davey M Smith; Sergei L Kosakovsky Pond; Caroline C Ignacio; Neil T Parkin; Christos J Petropoulos; Douglas D Richman
Journal:  J Virol       Date:  2008-03-19       Impact factor: 5.103
View more
  30 in total

1.  HIV-1 drug-resistant minority variants: sweating the small stuff.

Authors:  Jonathan Z Li
Journal:  J Infect Dis       Date:  2013-11-23       Impact factor: 5.226

2.  New antiretroviral agent use affects prevalence of HIV drug resistance in clinical care populations.

Authors:  Thibaut Davy-Mendez; Joseph J Eron; Laurence Brunet; Oksana Zakharova; Ann M Dennis; Sonia Napravnik
Journal:  AIDS       Date:  2018-11-13       Impact factor: 4.177

3.  Transmitted drug resistance and antiretroviral treatment outcomes in non-subtype B HIV-1-infected patients in South East Asia.

Authors:  Praphan Phanuphak; Sunee Sirivichayakul; Awachana Jiamsakul; Somnuek Sungkanuparph; Nagalingeswaran Kumarasamy; Man Po Lee; Thira Sirisanthana; Pacharee Kantipong; Christopher Lee; Adeeba Kamarulzaman; Mahiran Mustafa; Rossana Ditangco; Tuti Merati; Winai Ratanasuwan; Thida Singtoroj; Rami Kantor
Journal:  J Acquir Immune Defic Syndr       Date:  2014-05-01       Impact factor: 3.731

4.  Receipt and timing of HIV drug resistance testing in six U.S. jurisdictions.

Authors:  Sharoda Dasgupta; H Irene Hall; Angela L Hernandez; M Cheryl Bañez Ocfemia; Neeraja Saduvala; Alexandra M Oster
Journal:  AIDS Care       Date:  2017-05-03

5.  Transmitted, pre-treatment and acquired antiretroviral drug resistance among men who have sex with men and transgender women living with HIV in Nigeria.

Authors:  Trevor A Crowell; Gustavo H Kijak; Eric Sanders-Buell; Anne Marie O'Sullivan; Afoke Kokogho; Zahra F Parker; John Lawlor; Christina S Polyak; Sylvia Adebajo; Rebecca G Nowak; Stefan D Baral; Merlin L Robb; Manhattan E Charurat; Julie A Ake; Nicaise Ndembi; Sodsai Tovanabutra
Journal:  Antivir Ther       Date:  2019

6.  Fixed-dose combination emtricitabine/tenofovir/efavirenz initiated during acute HIV infection; 96-week efficacy and durability.

Authors:  Cynthia L Gay; Sarah J Willis; Anna B Cope; JoAnn D Kuruc; Kara S McGee; Joe Sebastian; Amanda M Crooks; Mehri S McKellar; David M Margolis; Susan A Fiscus; Charles B Hicks; Guido Ferrari; Joseph J Eron
Journal:  AIDS       Date:  2016-11-28       Impact factor: 4.177

7.  Clinical implications of HIV-1 minority variants.

Authors:  Jonathan Z Li; Daniel R Kuritzkes
Journal:  Clin Infect Dis       Date:  2013-02-27       Impact factor: 9.079

8.  Prevalence and virologic consequences of transmitted HIV-1 drug resistance in Uganda.

Authors:  Guinevere Q Lee; David R Bangsberg; Conrad Muzoora; Yap Boum; Jessica H Oyugi; Nneka Emenyonu; John Bennett; Peter W Hunt; David Knapp; Chanson J Brumme; P Richard Harrigan; Jeffrey N Martin
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-29       Impact factor: 2.205

9.  Transmitted antiretroviral drug resistance in the men who have sex with men HIV patient cohort, Beijing, China, 2008-2011.

Authors:  Lili Dai; Ning Li; Feili Wei; Jingyun Li; Yongjian Liu; Wei Xia; Tong Zhang; Caiping Guo; Wen Wang; Stanley A Schwartz; Supriya D Mahajan; Chiu-Bin Hsiao; Hao Wu
Journal:  Viral Immunol       Date:  2014-08-01       Impact factor: 2.257

10.  Understanding Local Spatial Variation Along the Care Continuum: The Potential Impact of Transportation Vulnerability on HIV Linkage to Care and Viral Suppression in High-Poverty Areas, Atlanta, Georgia.

Authors:  Neela D Goswami; Michelle M Schmitz; Travis Sanchez; Sharoda Dasgupta; Patrick Sullivan; Hannah Cooper; Deepali Rane; Jane Kelly; Carlos Del Rio; Lance A Waller
Journal:  J Acquir Immune Defic Syndr       Date:  2016-05-01       Impact factor: 3.731
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.